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The emergence of disease caused by penicillin-resistant and multidrug-resistant pneumococci has become a
global concern, necessitating the identification of the epidemiological spread of such strains. The Pneumo-
coccal Molecular Epidemiology Network was established in 1997 under the auspices of the International Union
of Microbiological Societies with the aim of characterizing, standardizing, naming, and classifying antimicro-
bial agent-resistant pneumococcal clones. Here we describe the nomenclature for 16 pneumococcal clones that
have contributed to the increase in antimicrobial resistance worldwide. Guidelines for the recognition of these
clones using molecular typing procedures (pulsed-field gel electrophoresis, BOX-PCR, and multilocus se-
quence typing) are presented, as are the penicillin-binding profiles and macrolide resistance determinants for
the 16 clones. This network can serve as a prototype for the collaboration of scientists in identifying clones of
important human pathogens and as a model for the development of other networks.
The emergence of penicillin-resistant and multidrug-resis-
tant pneumococcal strains has become a global concern. Since
the first description of pneumococci with decreased suscepti-
bilities to penicillin in Australia (18) in the late 1960s, penicil-
lin-resistant strains have been found in various parts of the
world with increasing frequency. Resistance to non-b-lactam
antibiotics such as chloramphenicol, tetracycline, erythromy-
cin, clindamycin, rifampin, and trimethoprim-sulfamethox-
azole also has been reported (2, 22) and often is associated
with decreased susceptibility to penicillin (1). Penicillin-resis-
tant pneumococci have been reported with particularly high
frequencies in Spain (14, 15), South Africa (22), and Hungary
(31) since the mid-1970s, in France (29), Iceland (52), and the
United States (48) since the middle to late 1980s and early
1990s, and in the Far East during the 1990s (21, 53).
Although the first penicillin-resistant pneumococcus was
identified in an adult (18), the first multidrug-resistant strains
were found in children (20), and penicillin-resistant strains
have been shown to be more common in children wherever
penicillin resistance has been studied. Penicillin-resistant (MICs
of $2 mg/ml) and multidrug-resistant pneumococci are known
to be restricted worldwide to a few serogroups, namely, 23, 6,
19, and 9, and serotype 14, which are particularly associated
with carriage and disease in children (10, 22).
The era of the global spread of penicillin-resistant pneumo-
cocci has seen the rapid development of DNA typing tech-
niques for use in research and epidemiological investigations.
Molecular studies have shown that the penicillin-resistant and
multidrug-resistant pneumococcal populations are highly dy-
namic and that resistance is a combination of the spread of
resistant clones, the acquisition and loss of resistance genes
within those clonal lineages, and the spread of resistance genes
to new lineages. Several techniques, including pulsed-field gel
electrophoresis (PFGE) (28), BOX-PCR (24, 60), and, more
recently, multilocus sequence typing (MLST) (13), have been
used to determine the genetic relatedness of pneumococcal
isolates. A search of the literature shows that extensive molec-
ular typing studies from various regions of the world have
identified a number of clones of antimicrobial-resistant pneu-
mococci that have achieved significant geographic spread
within individual countries and, in some cases, across interna-
tional boundaries.
The Pneumococcal Molecular Epidemiology Network
(PMEN) was established in 1997 under the auspices of the
International Union of Microbiological Societies with the aim
of standardizing the nomenclature and classification of resis-
tant pneumococcal clones worldwide. Specific objectives of the
network include the following: (i) international collaboration
and training support between laboratories and institutions; (ii)
increased knowledge of resistance and spread of pneumococci
worldwide; (iii) standardization of nomenclature of national
and international clones; (iv) identification of clones using
PFGE, BOX-PCR, and MLST; (v) availability of reference
isolates of each clone from the American Type Culture Col-
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lection (ATCC); and (vi) access to information through a web-
site.
The nomenclature of 16 national and international antibiot-
ic-resistant pneumococcal clones tested using PFGE, BOX-
PCR, and MLST is described. Penicillin-binding protein (PBP)
profiles and macrolide resistance determinants are also de-
scribed.
MATERIALS AND METHODS
Bacterial strains. Representative isolates for each of the 16 S. pneumoniae
clones were serotyped by the Quellung reaction, and MICs of penicillin, cefo-
taxime, erythromycin, clindamycin, chloramphenicol, tetracycline, and trimetho-
prim-sulfamethoxazole were determined according to National Committee for
Clinical Laboratory Standards criteria (39). ATCC accession numbers for the 16
clones are given in Table 1.
DNA fingerprinting. (i) BOX-PCR. Chromosomal DNA was isolated by the
method described by Ausubel et al. (3). DNA amplifications were performed
with 50-ml volumes containing 4 mM MgCl2, 2 mM primer AR1 (CTACG
GCAAGGCGACGCTGACG) (60), 150 mM each of the four deoxynucleoside
triphosphates (Roche Diagnostics, Mannheim, Germany), 20 ng of genomic
DNA, 1 U of Taq DNA polymerase (Advanced Biotechnologies, Epsom, United
Kingdom), and 5 ml of 103 reaction buffer. The reaction mixture was overlaid
with mineral oil and subjected to initial denaturation at 95°C for 5 min in a
Perkin-Elmer Cetus thermal cycler. This step was followed by 30 cycles of 1 min
at 90°C, 1 min at 52°C, and 2 min at 72° and a final extension at 72°C for 5 min.
PCR products were run on a 2% ethidium bromide-containing agarose gel in
Tris-acetate-EDTA buffer for 2 h at 120 V.
(ii) PFGE. Genomic DNA was prepared in situ in agarose blocks as described
previously (28, 33) and was digested with SmaI (Life Technologies, Gaithersburg,
Md.). The fragments were resolved by PFGE in 1% agarose (SeaKem GTG
agarose; BioWhittaker Molecular Applications, Rockland, Maine) in 0.53 Tris-
borate-EDTA buffer at 14°C and 6 V/cm in a CHEF-DR III system (Bio-Rad
Laboratories, Hercules, Calif.). The parameters for block 1 were an initial pulse
time of 1 s increased to 30 s over 17 h; those for block 2 were 5 s increased to 9 s
over 6 h.
(iii) MLST. MLST was carried out as described previously (13). Briefly, in-
ternal fragments of the aroE, gdh, gki, recP, spi, xpt, and ddl genes were amplified
by PCR from chromosomal DNA using the primer pairs described by Enright
and Spratt (13). The amplified fragments were directly sequenced in each direc-
tion using the primers that were used for the initial amplification. The sequences
at each of the seven loci were then compared with the sequences of all of the
known alleles at those loci. Sequences that were identical to the sequence of a
known allele were assigned the same allele number, whereas those that differed
from the sequence of any known allele, even at a single nucleotide site, were
assigned new allele numbers. The assignment of alleles at each locus was carried
out using the software available at the pneumococcal MLST website (http://www
.mlst.net). The alleles at each of the seven loci define the allelic profile of each
isolate as well as their sequence type. Allelic profiles are shown as a series of
seven integers which correspond to the alleles at each of the loci, in the order
aroE, gdh, gki, recP, spi, xpt, and ddl. The relatedness between the isolates was
represented as a dendrogram, constructed by the unweighted pair-group method
with arithmetic averages, from the matrix of pairwise differences in the allelic
profiles. The allelic profiles of the reference isolates of each clone are deposited
in the database at the pneumococcal MLST website.
PBP analysis. The genes encoding PBP1A, PBP2B, and PBP2X were ampli-
fied using primers and conditions previously described (7). Purified DNA frag-
ments were analyzed using the enzymes HinfI and MseI-DdeI for the PBP1A and
PBP2X genes and HinfI and StyI for the PBP2B gene. The samples were elec-
trophoresed at 120 V on a 2% agarose gel for 2 h and stained with ethidium
bromide.
Macrolide resistance determinants. A multiplex PCR using previously pub-
lished primers (55) was used to detect the mefA and ermB genes in S. pneumoniae
strains. Amplification reactions were performed with 50-ml volumes containing
13 reaction buffer; 5 mM MgCl2; 200 mM each dATP, dCTP, dGTP, and dTTP;
1 mM each primer; 1 U of Taq DNA polymerase; and 20 ng of DNA. Amplifi-
cation was performed with a Perkin-Elmer Cetus DNA thermal cycler pro-
grammed for 1 cycle of denaturation at 95°C for 2 min; 30 cycles of denaturation
at 95°C for 1 min, primer annealing at 56°C for 2 min, and extension at 72°C for
2 min; and 1 cycle of extension at 72°C for 10 min. Amplification products were
run on 2% agarose gels and detected by staining with ethidium bromide.
RESULTS
Nomenclature of clones. The following criteria were estab-
lished for inclusion of clones in the PMEN: (i) a clone must
have a wide geographic distribution throughout a country or
have spread internationally; (ii) a clone should be well estab-
lished within a country over a number of years; (iii) a clone
should be resistant to one or more antibiotics that are in wide
clinical use; (iv) data on the clone need to be published or in
press before ratification by the network; and (v) a representa-
tive isolate of the clone must be made available for confirma-
tion by molecular typing that it differs from previously ac-
cepted clones, and permission must be granted to deposit it
into the ATCC.
The system use for the naming of clones is as follows: coun-
tryfirst identified serotype-sequential numbering in network-subse-
quent described serotype. For example, in Spain23F-1, Spain is
TABLE 1. Properties of 16 pneumococcal clonesa
Clone Reference strain(ATCC accession no.) Serotype
MIC (mg/ml) of:
Reference(s)
PEN CTX ERY CLI CHL TET SXT
Spain23F-1 SP264 (ATCC 700669) 23F 2 0.5 0.06 0.06 16 32 4/76 7, 32, 37
Spain6B-2 GM17 (ATCC 700670) 6B 2 1 0.12 0.12 16 32 4/76 38
Spain9V-3 TL7/1993 (ATCC 700671) 9V 2 1 0.12 0.12 2 #0.5 8/152 7, 29
Tennessee23F-4 CS111 (ATCC 51916) 23F 0.12 32 32 0.12 2 #0.5 4/76 33, 49
Spain14-5 MS22 (ATCC 700902) 14 2 1 0.06 0.12 16 32 2/38 8
Hungary19A-6 HUN663 (ATCC 700673) 19A 2 0.5 .32 .32 16 16 2/38 31, 38
South Africa19A-7 17619 (ATCC 700674) 19A 0.5 0.5 0.25 0.25 2 #0.5 4/152 51
South Africa6B-8 50803 (ATCC 700675) 6B 0.5 0.25 0.12 0.12 2 #0.5 1/19 51
England14-9 PN93/872/B (ATCC 700676) 14 0.03 0.03 32 0.12 2 #0.5 0.12/4.2 17
CSR14-10 87-029055 (ATCC 700677) 14 8 1 .32 .32 16 32 0.25/4.8 16, 19
CSR19A-11 91-006571 (ATCC 700678) 19A 4 1 .32 .32 32 32 4/76 16, 19
Finland6B-12 43362 Fi10 (ATCC 700903) 6B 1 .32 .32 4 32 8/152 48
South Africa19A-13 51702 (ATCC 700904) 19A 8 2 .8 .8 32 8 8/152 51
Taiwan19F-14 TW31 (ATCC 700905) 19F 2 1 4 0.12 2 16 4/76 47
Taiwan23F-15 TW17 (ATCC 700906) 23F 1–2 1 .32 .32 2 16 0.5/9.5 47
Poland23F-16 178 23F 8 8 .8 0.25 16 16 4/76 41
a PEN, penicillin; CTX, cefotaxime; ERY, erythromycin; CLI, clindamycin; CHL, chloramphenicol; TET, tetracycline; SXT, trimethoprim-sulfamethoxazole; CSR,
Czech Republic.
2566 MCGEE ET AL. J. CLIN. MICROBIOL.
the country in which the clone was first identified (based on
publication), 23F is the serotype of the clone first identified,
and 1 is the clone number.
In large countries, such as the United States and Russia, the
naming of clones could be considered by province or state if
the clone is predominantly found in one region of the country,
for example, Tennessee23F-4.
Several publications have shown that members of a single
clone may express different capsular polysaccharides. In the
case of capsular switching, the nomenclature is, e.g., as follows:
in Spain23F-1-19F, 19F indicates a serotype 19F variant of the
Spain23F-1 clone.
DNA typing. Representative isolates of the 16 clones are
shown in Table 1; references indicate the first published re-
ports of the clones. Molecular typing of isolates of each of the
16 clones by BOX-PCR (Fig. 1), PFGE (Fig. 2), and MLST
(Table 2; Fig. 3) determined that their genotypes were suffi-
ciently different to distinguish them as distinct clones.
Resistance determinants. PBP fingerprinting results for the
PBP1A, PBP2B, and PBP2X genes are shown in Table 2.
Twelve patterns were identified for the PBP1A and PBP2X
genes, and 11 were identified for the PBP2B gene. The
Spain23F-1 and Spain9V-3 clones shared identical PBP profiles,
as did the two clones from the Czech Republic (CSR14-10 and
CSR19A-11).
The macrolide resistance determinants are shown in Table 2.
We identified the ermB gene in 6 of the 16 strains and the mefA
gene in 3. The Poland23F-16 clone, for which the erythromycin
MIC was .8 mg/ml, harbored neither the ermB nor the mefA
gene for macrolide resistance.
DISCUSSION
The global increase in highly penicillin-resistant and multi-
drug-resistant pneumococci appears, in large part, to result
from the spread of individual highly resistant pneumococcal
clones. This phenomenon has been particularly highlighted by
the worldwide spread of the serotype 23F pneumococcal clone
(Spain23F-1), first identified in Spain in the early 1980s (37) and
resistant to penicillin, chloramphenicol, and tetracycline (and
sometimes erythromycin). This successful clone has now been
found in the United States (26, 37), South Africa (23), the
United Kingdom (7), South America (5, 6, 12, 43), several
other countries in Europe (29, 30, 42, 46, 48, 50, 58, 61), and
the Far East (34, 47, 59). Serotype 19F (7), 14 (4), 19A (9), 9N
(40), and 3 (40) and serogroup 6 (54) variants of this clone
have also been reported in various regions of the world. Of
these serotype variants of the Spain23F-1 clone, those express-
ing the serotype 19F capsule are the most commonly encoun-
tered. A recent study conducted in the United States showed
that close to 40% of all highly penicillin-resistant pneumococci
belong to this Spain23F-1 clone (10).
The penicillin-resistant serotype 9V clone (Spain9V-3), first
identified in Spain (7) and France (29), has become widely
disseminated throughout the world and has been identified in
Italy (30), Sweden (35), Germany (42), the United States (10),
the United Kingdom (7), South America (6, 12), and the Far
East (34, 47). Serotype 14 (11, 36) and 9A (46) and serogroup
19 (10, 43) variants of this clone have been reported in numer-
ous countries. The serotype 14 variants of the Spain9V-3 clone
are the most commonly encountered.
The overwhelming majority of S. pneumoniae isolates for
which MICs were about 1.0 mg/ml or higher (107 of 119 iso-
lates, or 89.9%, collected during surveillance from 1996
through 1998) and colonizing the nasopharynges of children
attending day care centers in Lisbon, Portugal, belonged to
serotype variants of the Spain23F-1 and Spain9V-3 clones (44,
45).
The multidrug-resistant serotype 6B clone (Spain6B-2), re-
covered in Spain for over a decade, has become the dominant
pneumococcus isolated from children in Iceland (52), where it
accounts for approximately 75% of multidrug-resistant pneu-
FIG. 1. BOX-PCR fingerprint patterns of representative isolates of
the 16 clones described in Table 1. CSR, Czech Republic. Lanes M,
marker VI (Roche Diagnostics).
FIG. 2. PFGE fingerprint patterns of SmaI restriction digests of
representative isolates of the 16 clones described in Table 1.
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mococci (25). It has also been identified in other countries in
Europe (29, 42) and elsewhere, including the United Kingdom
(52), the United States (62), and Taiwan (47). Interestingly,
Vilhelmsson et al. (63) recently described the emergence of
antibiotic-resistant variants of this 6B clone in Iceland which
have lost one or more of the antibiotic resistance phenotypes
and/or resistance genes, singly or in combination.
Studies from other countries that have a high incidence of
antibiotic-resistant pneumococci have identified additional dis-
tinctive clones that have presumably emerged within these
countries. An example is the serotype 23F pneumococci resis-
tant to extended-spectrum cephalosporins and originally iso-
lated in Tennessee in the United States (33). This clone
(Tennessee23F-4), which probably evolved locally and is unre-
lated to the Spain23F-1 clone, is characterized by a mutation at
position 550 in the pbp2X gene which confers high-level ceph-
alosporin resistance. Pneumococci belonging to a multidrug-
resistant serotype 14 clone (Spain14-5) have been identified
among isolates recovered from six Spanish hospitals between
1990 and 1994 (8). A clone of multidrug-resistant serotype 19A
strains first identified in Hungary (Hungary19A-6) (31) has
been described in the Czech Republic and Slovakia (16). A
second, highly penicillin-resistant clone of serotype 19A
(CSR19A-10) and a serotype 14 clone (CSR14-11) have also
been described in Slovakia and the Czech Republic (16). An
analysis of a wide geographic diversity of resistant pneumococ-
cal isolates in South Africa has identified two clones of sero-
group 19A, one intermediately resistant to penicillin (South
Africa19A-7) and the other multiply resistant (South Africa19A-
13) (51). In addition, a unique penicillin-resistant serotype 6B
clone (South Africa6B-8) has emerged locally in South Africa
(51). The widespread use of erythromycin may have led to the
emergence of a serotype 14 clone (England14-9) resistant only
to erythromycin in various parts of the United Kingdom (17).
In Finland, pneumococcal strains resistant to multiple antibi-
otics have been characterized as belonging to a serogroup 6B
clone (Finland6B-12) (48). Shi et al. (47) have recently used
MLST to describe two antibiotic-resistant clones that have
emerged in Taiwan, a serotype 19F clone (Taiwan19F-14) and
a serotype 23F clone (Taiwan23F-15). The former clone has
been recovered from several countries in the Far East and
elsewhere (J. Zhou and B. G. Spratt, unpublished results).
Penicillin resistance among pneumococcal isolates has rapidly
emerged in Poland during the last decade. Although the pan-
demic Spain23F-1 and France9V-3 clones are present in that
country, a novel serotype 23F clone (Poland23F-16) has clearly
contributed to the increase in the prevalence of penicillin-
resistant pneumococci nationwide (41).
A search of the literature indicates that the initial charac-
terization of clones within a population of resistant pneumo-
cocci can be conveniently carried out using several molecular
typing methods, including BOX-PCR (60), repetitive extra-
genic palindromic-PCR (62), multilocus enzyme electropho-
resis (37), and PFGE (52). Most studies have analyzed peni-
cillin-resistant isolates, and each of the above techniques can
successfully identify clusters of closely related isolates within a
population. However, determination of whether clones are
novel or related to previously described clones is more prob-
lematic. Some of the clones are relatively old (e.g., 20 years),
and substantial variations may have accumulated in the PFGE
or BOX profiles of the descendents of the ancestral member of
a clone. It can therefore be difficult to decide whether a resis-
tant strain is sufficiently similar by PFGE or BOX-PCR anal-
ysis to be considered a member of a known clone or should be
considered a distinct and previously unrecognized clone.
MLST provides a less ambiguous and highly portable approach
to global epidemiological studies by defining the genotypes of
antibiotic-resistant isolates based on the alleles at each of
seven housekeeping loci (13, 47, 64). MLST studies have
shown that isolates of each of the Spain23F-1, Spain6B-2,
Spain9V-3, and Spain14-5 clones typically have identical allelic
profiles or differ from the typical profile at only one of the
seven loci (64). MLST therefore assigns an isolate as a member
of one of the resistant clones if it has the allelic profile of the
reference isolate of that resistant clone or differs from it at a
single locus. Isolates whose allelic profiles differ at three or
more of the seven loci used in MLST can be regarded as
distinct clones (13, 47, 64). Clearly, PFGE, BOX-PCR, and
TABLE 2. MLST allelic profiles, PBP profiles, and macrolide resistance determinants for 16 clonesa
Clone
MLST allele number for: Fingerprint pattern for:
Presence of erm or mef
aroE gdh gki recP spi xpt ddl PBP1A PBP2B PBP2X
Spain23F-1 4 4 2 4 4 1 1 1 1 1 2
Spain6B-2 5 6 1 2 6 3 4 1 2 2 2
Spain9V-3 7 11 10 1 6 8 1 1 1 1 2
Tennessee23F-4 1 8 6 2 6 4 6 2 3 1 mef
Spain14-5 1 5 4 11 9 3 16 3 4 1 2
Hungary19A-6 7 13 42 6 10 6 56 4 3 3 erm
South Africa19A-7 2 13 8 25 25 6 8 5 5 4 2
South Africa6B-8 7 22 1 2 5 1 14 6 3 5 2
England14-9 1 5 4 5 5 1 8 7 3 6 mef
CSR14-10 1 5 4 1 5 3 3 8 6 7 erm
CSR19A-11 7 5 4 26 10 3 55 8 6 7 erm
Finland6B-12 5 6 43 2 6 1 28 9 7 8 erm
South Africa19A-13 1 8 9 5 11 1 12 10 8 9 erm
Taiwan19F-14 15 16 19 15 6 20 26 11 9 10 mef
Taiwan23F-15 15 29 4 21 30 1 14 11 10 11 erm
Poland23F-16 7 13 8 1 10 6 36 12 11 12 2
a aroE, shikimate dehydrogenase; gdh, glucose-6-phosphate dehydrogenase; gki, glucose kinase; recP, transketolase; spi, signal peptidase I; xpt, xanthine phospho-
ribosyltransferase; ddl, D-alanine-D-alanine ligase; erm, ermB gene; mef, mefA gene; 2, neither gene was present.
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MLST results do correlate well, although the DNA fragment
patterns used in PFGE and BOX-PCR are believed to diversify
more rapidly than the allelic profiles used in MLST. Thus,
PFGE provides increased levels of discrimination which may
be useful for local epidemiological studies, whereas MLST
provides a more rigorous way of assigning isolates to one of the
major clones.
It should be remembered that similarity of genotype does
not necessarily imply that two resistant isolates are members of
the same clone. Penicillin resistance has emerged predomi-
nantly in a small number of serotypes, and although isolates of
the same serotype are often only distantly related in terms of
overall genotype (13), most isolates of a few serotypes appear
to have very similar genotypes (13, 57). For example, almost all
isolates of serotype 9V appear to be similar in genotype, and
two resistant clones of this serotype that emerged indepen-
dently will inevitably appear to be closely related (64). Rigor-
ous assignment of penicillin-resistant isolates to the same clone
should therefore also involve an analysis of their PBP1A,
PBP2B, and PBP2X genes. PBP analysis of the 16 clones
showed that the Spain23F-1 and Spain9V-3 clones harbored
identical PBP1A, PBP2B, and PBP2X genes (1-1-1), as previ-
ously described by Coffey et al. (7). The presence of identical
PBP genes (8-6-7) in the chromosomes of the two unrelated
FIG. 3. Dendrogram constructed from MLST data showing the genetic relatedness of the 16 pneumococcal clones described in Table 1.
VOL. 39, 2001 PNEUMOCOCCAL NETWORK 2569
clones from the Czech Republic and Slovakia (CSR14-10 and
CSR19A-11) suggests the horizontal transfer of these PBP
genes.
Nine of the 16 clones were resistant to erythromycin, and 6
clones carried the ermB resistance determinant, which codes
for target modification by 23S rRNA methylase (27). Three
isolates showed the M phenotype (macrolide resistant but clin-
damycin and streptogramin B susceptible) and carried the
mefA gene, which codes for an efflux mechanism (56).
In conclusion, the PMEN includes the molecular character-
ization and nomenclature of 16 important national and inter-
national antibiotic-resistant clones that have contributed to the
rapid increase in resistance in pneumococci worldwide. The
biological basis of the successful spread of these particular
clones remains to be established.
ACKNOWLEDGMENT
The establishment and continued work of the network have been
made possible by financial support from the ICSU.
REFERENCES
1. Allen, K. D. 1991. Penicillin-resistant pneumococci. J. Hosp. Infect. 17:3–13.
2. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneu-
moniae: an overview. Clin. Infect. Dis. 15:77–83.
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A.
Smith, and K. Struhl. 1998. Short protocols in molecular biology, p. 61–63.
John Wiley & Sons, Inc., New York, N.Y.
4. Barnes, D. M., S. Wittier, P. H. Gilligan, S. Soares, A. Tomasz, and F. W.
Henderson. 1995. Transmission of multidrug-resistant serotype 23F Strepto-
coccus pneumoniae in group day care: evidence suggesting capsular trans-
formation of the resistant strain in vivo. J. Infect. Dis. 171:890–896.
5. Camou, T., M. Hortal, and A. Tomasz. 1998. The apparent importation of
penicillin-resistant capsular type 14 Spanish/French clone of Streptococcus
pneumoniae into Uruguay in the early 1990s. Microb. Drug Resist. 4:219–
224.
6. Castan˜eda, E., A. Tomasz, and M. C. T. Vela. 1998. Penicillin-resistant
Streptococcus pneumoniae in Colombia: presence of international epidemic
clones. Microb. Drug Resist. 4:233–239.
7. Coffey, T. J., C. G. Dowson, M. Daniels, J. Zhou, C. Martin, B. G. Spratt, and
J. M. Musser. 1991. Horizontal transfer of multiple penicillin-binding pro-
tein genes, and capsular biosynthetic genes, in natural populations of Strep-
tococcus pneumoniae. Mol. Microbiol. 5:2255–2260.
8. Coffey, T. J., S. Berro´n, M. Daniels, E. Garcia-Leoni, E. Cercenado, E.
Bouza, A. Fenoll, and B. G. Spratt. 1996. Multiply antibiotic-resistant Strep-
tococcus pneumoniae recovered from Spanish hospitals (1988–1994): novel
major clones of serotypes 14, 19F and 15F. Microbiology 142:2747–2757.
9. Coffey, T. J., M. C. Enright, M. Daniels, P. Wilkinson, S. Berro´n, A. Fenoll,
and B. G. Spratt. 1998. Serotype 19A variants of the Spanish serotype 23F
multiresistant clone of Streptococcus pneumoniae. Microb. Drug Resist. 4:51–
55.
10. Corso, A., E. P. Severina, V. F. Petruk, Y. R. Mauriz, and A. Tomasz. 1998.
Molecular characterization of penicillin-resistant Streptococcus pneumoniae
isolates causing respiratory disease in the United States. Microb. Drug.
Resist. 4:325–337.
11. Doit, C., E. Denamur, B. Picard, P. Geslin, J. Elion, and E. Bingen. 1996.
Mechanisms of the spread of penicillin resistance in Streptococcus pneu-
moniae strains causing meningitis in children in France. J. Infect. Dis. 174:
520–528.
12. Echa´niz-Aviles, M., N. Carnalla-Barajas, M. E. Vela`zquez-Meza, A. Soto-
Noguero´n, L. E. Espinoza-de los Monteros, and F. Solo´rzano-Santos. 1995.
Capsular types of Streptococcus pneumoniae causing disease in children from
Mexico City. Pediatr. Infect. Dis. J. 14:907–909.
13. Enright, M. C., and B. G. Spratt. 1998. A multilocus sequence typing scheme
for Streptococcus pneumoniae: identification of clones associated with serious
invasive disease. Microbiology 144:3049–3060.
14. Fenoll, A., M. Bourgon, R. Munoz, D. Vicioso, and J. Casal. 1991. Serotype
distribution and antimicrobial resistance of Streptococcus pneumoniae iso-
lates causing systemic infections in Spain, 1979–1989. Rev. Infect. Dis. 13:
56–60.
15. Fenoll, A., I. Jado, D. Vicioso, A. Pe´rez, and J. Casal. 1998. Evolution of
Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: up-
date (1990–1996). J. Clin. Microbiol. 36:3447–3454.
16. Figueiredo, A. M., R. Austrian, P. Urbaskova, L. A. Teixeira, and A. Tomasz.
1995. Novel penicillin-resistant clones of Streptococcus pneumoniae in the
Czech Republic and Slovakia. Microb. Drug Resist. 1:71–78.
17. Hall, L. M., R. A. Whiley, B. Duke, R. C. George, and A. Efstratiou. 1996.
Genetic relatedness within and between serotypes of Streptococcus pneu-
moniae from the United Kingdom: analysis of multilocus enzyme electro-
phoresis, pulsed-field gel electrophoresis, and antimicrobial resistance pat-
terns. J. Clin. Microbiol. 34:853–859.
18. Hansman, D., and M. M. Bullen. 1967. A resistant pneumococcus. Lancet ii:
264–265.
19. Jabes, D., S. Nachman, and A. Tomasz. 1989. Penicillin-binding protein
families: evidence for the clonal nature of penicillin-resistance in clinical
isolates of pneumococci. J. Infect. Dis. 159:16–25.
20. Jacobs, M. R., H. J. Koornhof, R. M. Robins-Browne, C. M. Stevenson, Z. A.
Vermaak, I. Freiman, G. B. Miller, M. A. Witcomb, M. Isaacson, J. I. Ward,
and R. Austrian. 1978. Emergence of multiply resistant pneumococci.
N. Engl. J. Med. 299:735–740.
21. Kam, K. M., K. Y. Luey, S. M. Fung, P. P. Yiu, T. J. Harden, and M. M.
Cheung. 1995. Emergence of multiple-antibiotic-resistant Streptococcus
pneumoniae in Hong Kong. Antimicrob. Agents Chemother. 39:2667–2670.
22. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Micro-
biol. Rev. 3:171–196.
23. Klugman, K. P., T. J. Coffey, A. Smith, A. Wasas, M. Meyers, and B. G.
Spratt. 1994. Cluster of erythromycin-resistant variant of the Spanish mul-
tiply resistant 23F clone of Streptococcus pneumoniae in South Africa. Eur.
J. Clin. Microbiol. Infect. Dis. 13:171–174.
24. Koeuth, T., J. Versalovic, and J. R. Lupski. 1995. Differential subsequence
conservation of interspersed repetitive Streptococcus pneumoniae BOX ele-
ments in diverse bacteria. Genome Res. 5:408–418.
25. Kristinsson, K. G. 1995. Epidemiology of penicillin-resistant pneumococci in
Iceland. Microb. Drug Resist. 1:121–125.
26. Laible, G., B. G. Spratt, and R. Hakenbeck. 1991. Interspecies recombina-
tional events during the evolution of altered PBP2X genes in penicillin-
resistant clinical isolates of Streptococcus pneumoniae. Mol. Microbiol.
5:1993–2202.
27. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide,
lincosamide, and streptogramin antibiotics by target modification. Antimi-
crob. Agents Chemother. 35:1267–1272.
28. Lefe`vre, J. C., G. Faucon, A. M. Sicard, and A. M. Gasc. 1993. DNA
fingerprinting of Streptococcus pneumoniae strains by pulsed-field gel elec-
trophoresis. J. Clin. Microbiol. 31:2724–2728.
29. Lefe`vre, J. C., M. A. Bertrand, and G. Faucon. 1995. Molecular analysis by
pulsed-field gel electrophoresis of penicillin-resistant Streptococcus pneu-
moniae from Toulouse, France. Eur. J. Clin. Microbiol. Infect. Dis. 14:491–
497.
30. Marchese, A., M. Ramirez, G. C. Schito, and A. Tomasz. 1998. Molecular
epidemiology of penicillin-resistant Streptococcus pneumoniae isolates recov-
ered in Italy from 1993 to 1996. J. Clin. Microbiol. 36:2944–2949.
31. Marton, A., M. Gulyas, R. Munoz, and A. Tomasz. 1991. Extremely high
incidence of antibiotic resistance in clinical isolates of Streptococcus pneu-
moniae in Hungary. J. Infect. Dis. 163:542–548.
32. McDougal, L. K., R. Facklam, M. Reeves, S. Hunter, J. M. Swenson, B. C.
Hill, and F. C. Tenover. 1992. Analysis of multiply antimicrobial-resistant
isolates of Streptococcus pneumoniae from the United States. Antimicrob.
Agents Chemother. 36:2176–2184.
33. McDougal, L. K., J. K. Rasheed, J. W. Biddle, and F. C. Tenover. 1995.
Identification of multiple clones of extended-spectrum cephalosporin-resis-
tant Streptococcus pneumoniae isolates in the United States. Antimicrob.
Agents Chemother. 39:2282–2288.
34. McGee, L., K. P. Klugman, D. Friedland, and H. J. Lee. 1997. Spread of the
Spanish multi-resistant serotype 23F clone of Streptococcus pneumoniae to
Seoul, Korea. Microb. Drug Resist. 3:253–257.
35. Melander, E., K. Ekdahl, H. B. Hansson, C. Kamme, M. Laurell, P. Nilsson,
K. Persson, M. So¨derstro¨m, and S. Mo¨lstad. 1998. Introduction and clonal
spread of penicillin- and trimethoprim-sulphamethoxazole-resistant Strepto-
coccus pneumoniae, serotype 9V, in southern Sweden. Microb. Drug Resist.
4:71–78.
36. Moissenet, D., M. Valcin, V. Marchand, E.-N. Garabe´dian, P. Geslin, A.
Garbarg-Chenon, and H. Vu-Thien. 1997. Molecular epidemiology of Strep-
tococcus pneumoniae with decreased susceptibility to penicillin in a Paris
children’s hospital. J. Clin. Microbiol. 35:298–301.
37. Munoz, R., T. J. Coffey, M. Daniels, C. G. Dowson, G. Laible, J. Casal, R.
Hakenbeck, M. Jacobs, J. M. Musser, B. G. Spratt, and A. Tomasz. 1991.
Intercontinental spread of a multiresistant clone of serotype 23F Streptococ-
cus pneumoniae. J. Infect. Dis. 164:302–306.
38. Munoz, R., J. M. Musser, M. Crain, D. E. Briles, A. Marton, A. J. Parkinson,
U. Sorensen, and A. Tomasz. 1992. Geographic distribution of penicillin-
resistant clones of Streptococcus pneumoniae: characterisation by penicillin-
binding protein profile, surface protein A typing, and multilocus enzyme
analysis. Clin. Infect. Dis. 15:112–118.
39. National Committee for Clinical Laboratory Standards. 2000. Methods for
dilution antimicrobial susceptibility tests for bacteria that grow aerobically,
5th ed. Publication M7–A5. National Committee for Clinical Laboratory
Standards, Wayne, Pa.
2570 MCGEE ET AL. J. CLIN. MICROBIOL.
40. Nesin, M., M. Ramirez, and A. Tomasz. 1998. Capsular transformation of a
multi-drug resistant Streptococcus pneumoniae in vivo. J. Infect. Dis. 177:
707–713.
41. Overweg, K., P. W. M. Hermans, K. Trzcinski, M. Sluijter, R. de Groot, and
W. Hryniewicz. 1999. Multidrug-resistant Streptococcus pneumoniae in Po-
land: identification of emerging clones. J. Clin. Microbiol. 37:1739–1745.
42. Reichmann, P., E. Varon, E. Gunther, R. R. Reinert, R. Luttiken, A. Marton,
P. Geslin, J. Wagner, and R. Hakenbeck. 1995. Penicillin-resistant Strepto-
coccus pneumoniae in Germany: genetic relationship to clones from other
European countries. J. Med. Microbiol. 43:377–385.
43. Rossi, A., A. Corso, J. Pace, M. Regueira, and A. Tomasz. 1998. Penicillin-
resistant Streptococcus pneumoniae in Argentina: frequent occurrence of an
internationally spread serotype 14. Microb. Drug Resist. 4:225–231.
44. Sa´-Lea˜o, R., A. Tomasz, I. Santos Sanches, A. Brito-Avoˆ, S. E. Vilhelmsson,
K. G. Kristinsson, and H. de Lencastre. 2000. Carriage of internationally-
spread epidemic clones of Streptococcus pneumoniae with unusual drug re-
sistance patterns in children attending day care centers in Lisbon, Portugal.
J. Infect. Dis. 182:1153–1160.
45. Sa´-Lea˜o, R., A. Tomasz, I. Santos Sanches, S. Nunes, C. R. Alves, A. Brito-
Avoˆ, J. Saldanha, K. G. Kristinsson, and H. de Lencastre. 2000. Genetic
diversity and clonal patterns among antibiotic-susceptible and -resistant
Streptococcus pneumoniae colonizing children: day care centers as autono-
mous epidemiological units. J. Clin. Microbiol. 38:4137–4144.
46. Setchanova, L., and A. Tomasz. 1999. Molecular characterization of penicil-
lin-resistant Streptococcus pneumoniae isolates from Bulgaria. J. Clin. Mi-
crobiol. 37:638–648.
47. Shi, Z.-Y., M. C. Enright, P. Wilkinson, D. Griffiths, and B. G. Spratt. 1998.
Identification of the three major clones of multiply antibiotic-resistant Strep-
tococcus pneumoniae in Taiwanese hospitals by multilocus sequencing typ-
ing. J. Clin. Microbiol. 36:3514–3519.
48. Sibold, C., J. Wang, J. Henrichsen, and R. Hakenbeck. 1992. Genetic rela-
tionships of penicillin-susceptible and -resistant Streptococcus pneumoniae
strains isolated on different continents. Infect. Immun. 60:4119–4126.
49. Sloas, M. M., F. F. Barrett, P. J. Chesney, B. K. English, B. C. Hill, F. C.
Tenover, and R. J. Leggiadro. 1992. Cephalosporin treatment failure in
penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis.
Pediatr. Infect. Dis. 11:662–666.
50. Sluijter, M., H. Faden, R. de Groot, N. Lemmens, W. H. F. Goessens, A. van
Belkum, and P. W. M. Hermans. 1998. Molecular characterization of pneu-
mococcal nasopharynx isolates collected from children during their first 2
years of life. J. Clin. Microbiol. 36:2248–2253.
51. Smith, A. M., and K. P. Klugman. 1997. Three predominant clones identified
within penicillin-resistant South African isolates of Streptococcus pneu-
moniae. Microb. Drug Resist. 3:385–389.
52. Soares, S., K. G. Kristinsson, J. M. Musser, and A. Tomasz. 1993. Evidence
for the introduction of a multiresistant clone of serotype 6B Streptococcus
pneumoniae from Spain to Iceland in the late 1980s. J. Infect. Dis. 168:158–
163.
53. Song, J.-H., N. Y. Lee, S. Ichiyama, R. Yoshida, Y. Hirakata, W. Fu, A.
Chongthaleong, N. Aswapokee, C.-H. Chiu, M. K. Lalitha, K. Thomas, J.
Perera, T. T. Yee, F. Jamal, U. C. Warsa, B. X. Vinh, M. R. Jacobs, P. C.
Appelbaum, C. H. Pai, and the ANSORP Study Group. 1999. Spread of
drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network
for Surveillance of Resistant Pathogens (ANSORP) study. Clin. Infect. Dis.
28:1206–1211.
54. Song, J.-H., J.-W. Yang, J. H. Jin, S. W. Kim, C. K. Kim, H. Lee, K. R. Peck,
S. Kim, N. Y. Lee, M. R. Jacobs, P. C. Appelbaum, and the Asian Network
for Surveillance of Resistant Pathogens (ANSORP) Study Group. 2000.
Molecular characterization of multidrug-resistant Streptococcus pneumoniae
isolates in Korea. J. Clin. Microbiol. 38:1641–1644.
55. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneu-
moniae and Streptococcus pyogenes resistant to macrolides but sensitive to
clindamycin: a common resistance pattern mediated by an efflux system.
Antimicrob. Agents Chemother. 40:1817–1824.
56. Tait-Kamradt, A., J. Clancy, M. Cronan, F. Dib-Hajj, L. Wondrack, W.
Yuan, and J. Sutcliffe. 1997. mefE is necessary for the erythromycin-resistant
M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother.
41:2251–2255.
57. Takala, A. K., J. Vuopio-Varkila, E. Tarkka, M. Leinonen, and J. M. Musser.
1996. Subtyping of common pediatric pneumococcal serotypes from invasive
disease and pharyngeal carriage in Finland. J. Infect. Dis. 173:128–135.
58. Tarasi, A., N. Sterk-Kuzmanovic, K. Sieradzki, S. Schoenwald, R. Austrian,
and A. Tomasz. 1995. Penicillin-resistant and multidrug-resistant Streptococ-
cus pneumoniae in a paediatric hospital in Zagreb, Croatia. Microb. Drug
Resist. 1:169–176.
59. Tarasi, A., Y. Chong, K. Lee, and A. Tomasz. 1997. Spread of the serotype
23F multidrug-resistant Streptococcus pneumoniae clone to South Korea.
Microb. Drug Resist. 3:105–109.
60. Van Belkum, A., M. Sluijter, R. de Groot, H. Verbrugh, and P. W. M.
Hermans. 1996. Novel BOX repeat PCR assay for high-resolution typing of
Streptococcus pneumoniae strains. J. Clin. Microbiol. 34:1176–1179.
61. Vaz Pato, M. V., C. B. de Carvalho, A. Tomasz, and the Multicenter Study
Group. 1995. Antibiotic susceptibility of Streptococcus pneumoniae isolates in
Portugal. A multicenter study between 1989 and 1993. Microb. Drug Resist.
1:59–69.
62. Versalovic, J., V. Kapur, E. O. Mason, U. Shah, T. Koeuth, J. R. Lupski, and
J. M. Musser. 1993. Penicillin-resistant Streptococcus pneumoniae strains
recovered in Houston: identification and molecular characterization of mul-
tiple clones. J. Infect. Dis. 167:850–856.
63. Vilhelmsson, S. E., A. Tomasz, and K. G. Kristinsson. 2000. Molecular
evolution in a multidrug-resistant lineage of Streptococcus pneumoniae:
emergence of strains belonging to the serotype 6B Icelandic clone that lost
antibiotic resistance traits. J. Clin. Microbiol. 38:1375–1381.
64. Zhou, J., M. C. Enright, and B. G. Spratt. 2000. Identification of the major
Spanish clones of penicillin-resistant pneumococci via the Internet using
multilocus sequence typing. J. Clin. Microbiol. 38:977–986.
VOL. 39, 2001 PNEUMOCOCCAL NETWORK 2571
